Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Unavailable
    Regulatory Affairs for Biomaterials and Medical Devices
    Unavailable
    Regulatory Affairs for Biomaterials and Medical Devices
    Unavailable
    Regulatory Affairs for Biomaterials and Medical Devices
    Ebook413 pages9 hours

    Regulatory Affairs for Biomaterials and Medical Devices

    ()

    Currently unavailable

    Currently unavailable

    About this ebook

    All biomaterials and medical devices are subject to a long list of regulatory practises and policies which must be adhered to in order to receive clearance. This book provides readers with information on the systems in place in the USA and the rest of the world. Chapters focus on a series of procedures and policies including topics such as commercialization, clinical development, general good practise manufacturing and post market surveillance.
    • Addresses global regulations and regulatory issues surrounding biomaterials and medical devices
    • Especially useful for smaller companies who may not employ a full time vigilance professional
    • Focuses on procedures and policies including risk management, intellectual protection, marketing authorisation, university patent licenses and general good practise manufacturing
    LanguageEnglish
    PublisherElsevier Science
    Release dateOct 27, 2014
    ISBN9780857099204
    Unavailable
    Regulatory Affairs for Biomaterials and Medical Devices

    Related to Regulatory Affairs for Biomaterials and Medical Devices

    Related ebooks

    Administrative Law & Regulatory Practice For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Indian Pharma's Big Leap

      Apr 30, 2018

      Indian Pharma's Big Leap
      6 min read

    • Article

      Opinion: Companies Must Responsibly Manufacture The Antimicrobials Society Needs

      Jan 30, 2020

      Providing access to antibiotics and other antimicrobials while reducing resistance to these medicines presents a dual manufacturing challenge: ensuring a cost-effective supply while minimizing their emission into the environment.

      4 min read

    • Article

      Opinion: Bringing Order To The ‘Wild Frontier’ Of Microbiome Medicine

      Oct 2, 2018

      When it comes to #microbiome medicine, @US_FDA and @NIH need to create a solid, science-based regulatory framework to help realize the promise of living drugs.

      4 min read

    • Article

      Cancer The New Cures

      Sep 24, 2022

      Cancer The New Cures
      17 min read

    • Article

      Opinion: Synthetic Control Arms Can Save Time And Money In Clinical Trials

      Feb 5, 2019

      Synthetic control arms aren't the solution to all of the challenges facing randomized trials, but they represent a great way for drug development companies to start using real-world evidence.

      4 min read

    • Article

      Covid Vaccines Compared: What Are The Differences Between Pfizer, Moderna, Oxford-AstraZeneca And Novavax? - OLD

      Jan 29, 2021

      After almost a year in which the entire world has been paralysed by coronavirus, a way out is finally in sight through the Covid-19 vaccines. The past few months have brought positive news of candidates from Pfizer, Moderna, Oxford University with As

      9 min read

    • Article

      Beating Cancer

      Feb 1, 2019

      Is cancer still a death sentence? No. Most cancers are preventable and also treatable. Cancer diagnosis and treatment have grown by leaps and bounds. We know the cause of at least 70 per cent of cancers now, around 60 per cent of cancers are now prev

      4 min read

    • Article

      Opinion: From Bench To Bedside, Biologics Require Excellence At Every Stage

      Feb 13, 2020

      Quality and trust go together. As an industry, biologic manufacturers must deliver on quality. Public trust of sophisticated biological products will follow.

      3 min read

    • Article

      The History Of GE

      Jun 19, 2022

      The History Of GE
      7 min read

    • Article

      Q & A

      Nov 27, 2021

      With the COVID19 pandemic exerting enormous pressure on the healthcare infrastructure, the sector finds itself under the compulsion to step up. In this interview Dr. G.V. Sampath, Chairman, Naruvi Hospitals, Vellore addresses how India can make optim

      2 min read

    • Article

      Bibliography

      Jan 22, 2020

      1. Al Gore, our Choice, A plan to solve the climate crisis; Melcher Media). 2. Jeff Tollefson nature, international journal of science, China declared worlds largest producer of scientific articles-, 2018 Science & Enginering indicators, National Sci

      10 min read

    • Article

      From The Editor-in-chief

      Sep 24, 2022

      Long before Covid-19 entered our lexicon, cancer was the Big C. And long after that virus of unknown origin slips into history—or becomes a tame omnipresence like the common cold—the mysteries of cancer will still loom menacingly in our midst. In fac

      4 min read

    • Article

      Opinion: Welcome To The Bioengineering Culture Clash

      Jan 10, 2020

      The audacious dream of engineering biology on a molecular scale is finally being realized, not just in practice but commercially — if we can surmount the culture clashes.

      4 min read

    • Article

      Opinion: Enough With The Me-too Drugs. New Treatments Should Be Worthy Of The People Who Invest Their Lives In Clinical Trials

      Sep 4, 2019

      Drug developers should should treat patients who volunteer for clinical trials the way they would treat their mothers or husbands or best friends — but often don't.

      3 min read

    • Article

      Merck And Sanofi Buy Smaller Cancer Drug Firms At Big Premiums, Fueling Investor Excitement

      Dec 9, 2019

      Merger Monday: Merck announces it will purchase ArQule, a developer of pills aimed at treating multiple cancers, and Sanofi says it will buy Synthorx, a San Diego firm working on…

      3 min read

    Related categories

    Reviews for Regulatory Affairs for Biomaterials and Medical Devices

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words